IvyRock Asset Management »

Arrowhead Pharmaceuticals shares owned by IvyRock Asset Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by IvyRock Asset Management from 13F filings

Historical chart of IvyRock Asset Management investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by IvyRock Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by IvyRock Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $362k 11k 34.49

More positions owned by IvyRock Asset Management

Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp Sponsored Ads (LEGN)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Zai Lab Adr (ZLAB)
Spdr Gold Tr Gold Shs (GLD)
Bloom Energy Corp Com Cl A (BE)
Direxion Shs Etf Tr Daily S&p Biotch (LABU)
So Young International Sponsored Ads (SY)
Microsoft Corporation (MSFT)
Arrowhead Pharmaceuticals (ARWR)
Advanced Micro Devices (AMD)
Cisco Systems (CSCO)
Intellia Therapeutics (NTLA)

View all positions for IvyRock Asset Management

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
Geode Capital Management
Siren
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Ubs Global Asset Management Americas
Morgan Stanley
Baker Bros. Advisors
Marshall Wace

View all funds holding Arrowhead Pharmaceuticals